CL
VENTE TOTALE: 326 212 titres (~30 087 974,53 $ US)
- Insiders
- CAHILL JOHN T, Wallace Noel R.
- Total bought
- —
- Total sold
- $30,087,975
- Last activity
- 2026-08-06
- Last synced
-
2026-08-12 09:47:22
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-26
CL presents a deeply unfavorable risk/reward profile: a weak liquidity score (45) combined with extreme financial leverage (ratio >300) and a current ratio below 1.0 signal meaningful balance sheet fragility despite…
The first sentence of the analysis written for CL on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 60.1% | 60.2% | 57.8% | 56.5% | 59.1% | |
| Ebit Margin | 16.3% | 21.1% | 18.9% | 15.7% | 18.4% | |
| Ebitda Margin | 19.4% | 24.1% | 21.8% | 18.8% | 21.6% | |
| Operating Profit Margin | 21.3% | 21.8% | 21.2% | 20.0% | 22.3% | |
| Pretax Profit Margin | 15.0% | 19.7% | 17.4% | 14.8% | 17.7% | |
| Continuous Operations Profit Margin | 11.1% | 15.2% | 12.6% | 10.9% | 13.4% | |
| Net Profit Margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | |
| Bottom Line Profit Margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | |
| Current Ratio | 0.995 | 0.923 | 1.113 | 1.277 | 1.085 | |
| Quick Ratio | 0.641 | 0.578 | 0.706 | 0.759 | 0.668 | |
| Solvency Ratio | 0.173 | 0.225 | 0.186 | 0.156 | 0.193 | |
| Cash Ratio | 0.225 | 0.190 | 0.204 | 0.194 | 0.205 | |
| Price To Earnings Ratio | 29.932 | 25.754 | 28.673 | 36.991 | 33.336 | |
| Price To Earnings Growth Ratio | -1.187 | 0.955 | 0.940 | -2.202 | -1.780 | |
| Forward Price To Earnings Growth Ratio | -1.187 | 0.955 | 0.940 | -2.202 | -1.780 | |
| Price To Earnings Diluted Ratio | 30.046 | 25.900 | 28.776 | 36.991 | 33.467 | |
| Price To Earnings Diluted Growth Ratio | -1.198 | 0.970 | 0.958 | -2.246 | -1.781 | |
| Price To Book Ratio | 1,183.398 | 350.647 | 108.296 | 164.339 | 118.411 | |
| Price To Sales Ratio | 3.135 | 3.698 | 3.390 | 3.668 | 4.139 | |
| Price To Free Cash Flow Ratio | 17.585 | 20.964 | 21.695 | 35.430 | 26.147 | |
| Price To Operating Cash Flow Ratio | 15.222 | 18.100 | 17.611 | 25.782 | 21.688 | |
| Debt To Assets Ratio | 0.489 | 0.530 | 0.553 | 0.589 | 0.521 | |
| Debt To Equity Ratio | 147.926 | 40.151 | 14.883 | 23.120 | 12.862 | |
| Debt To Capital Ratio | 0.993 | 0.976 | 0.937 | 0.959 | 0.928 | |
| Long Term Debt To Capital Ratio | 0.993 | 0.972 | 0.931 | 0.956 | 0.922 | |
| Financial Leverage Ratio | 302.407 | 75.689 | 26.918 | 39.229 | 24.696 | |
| Working Capital Turnover Ratio | -86.917 | 418.771 | 23.627 | 24.697 | 124.436 | |
| Operating Cash Flow Ratio | 0.732 | 0.713 | 0.790 | 0.638 | 0.821 | |
| Operating Cash Flow Sales Ratio | 0.206 | 0.204 | 0.192 | 0.142 | 0.191 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.866 | 0.863 | 0.812 | 0.728 | 0.829 | |
| Debt Service Coverage Ratio | 11.828 | 4.145 | 5.363 | 13.953 | 17.923 | |
| Interest Coverage Ratio | 16.285 | 15.010 | 14.394 | 21.467 | 33.214 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 6.223 | 11.348 | 102.240 | 65.196 | |
| Operating Cash Flow Coverage Ratio | 0.526 | 0.482 | 0.413 | 0.276 | 0.424 | |
| Capital Expenditure Coverage Ratio | 7.443 | 7.321 | 5.312 | 3.672 | 5.864 | |
| Dividend Paid And Capex Coverage Ratio | 1.759 | 1.748 | 1.526 | 1.071 | 1.480 | |
| Dividend Payout Ratio | 0.855 | 0.619 | 0.760 | 0.947 | 0.775 | |
| Enterprise Value Multiple | 17.847 | 16.846 | 17.440 | 22.063 | 21.041 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 60.1% | ▼-0.1% | ▲1.4% |
| Ebit Margin | 16.3% | ▼-4.8% | ▼-1.8% |
| Ebitda Margin | 19.4% | ▼-4.7% | ▼-1.7% |
| Operating Profit Margin | 21.3% | ▼-0.5% | ▲0.0% |
| Pretax Profit Margin | 15.0% | ▼-4.7% | ▼-1.9% |
| Continuous Operations Profit Margin | 11.1% | ▼-4.1% | ▼-1.6% |
| Net Profit Margin | 10.5% | ▼-3.9% | ▼-1.3% |
| Bottom Line Profit Margin | 10.5% | ▼-3.9% | ▼-1.3% |
| Current Ratio | 0.995 | ▲0.072 | ▼-0.084 |
| Quick Ratio | 0.641 | ▲0.063 | ▼-0.029 |
| Solvency Ratio | 0.173 | ▼-0.052 | ▼-0.014 |
| Cash Ratio | 0.225 | ▲0.034 | ▲0.021 |
| Price To Earnings Ratio | 29.932 | ▲4.178 | ▼-1.005 |
| Price To Earnings Growth Ratio | -1.187 | ▼-2.142 | ▼-0.532 |
| Forward Price To Earnings Growth Ratio | -1.187 | ▼-2.142 | ▼-0.532 |
| Price To Earnings Diluted Ratio | 30.046 | ▲4.145 | ▼-0.990 |
| Price To Earnings Diluted Growth Ratio | -1.198 | ▼-2.168 | ▼-0.539 |
| Price To Book Ratio | 1183.398 | ▲832.751 | ▲798.380 |
| Price To Sales Ratio | 3.135 | ▼-0.563 | ▼-0.471 |
| Price To Free Cash Flow Ratio | 17.585 | ▼-3.379 | ▼-6.779 |
| Price To Operating Cash Flow Ratio | 15.222 | ▼-2.878 | ▼-4.458 |
| Debt To Assets Ratio | 0.489 | ▼-0.041 | ▼-0.047 |
| Debt To Equity Ratio | 147.926 | ▲107.775 | ▲100.138 |
| Debt To Capital Ratio | 0.993 | ▲0.018 | ▲0.035 |
| Long Term Debt To Capital Ratio | 0.993 | ▲0.021 | ▲0.038 |
| Financial Leverage Ratio | 302.407 | ▲226.719 | ▲208.619 |
| Working Capital Turnover Ratio | -86.917 | ▼-505.688 | ▼-187.840 |
| Operating Cash Flow Ratio | 0.732 | ▲0.019 | ▼-0.007 |
| Operating Cash Flow Sales Ratio | 0.206 | ▲0.002 | ▲0.019 |
| Free Cash Flow Operating Cash Flow Ratio | 0.866 | ▲0.002 | ▲0.046 |
| Debt Service Coverage Ratio | 11.828 | ▲7.683 | ▲1.185 |
| Interest Coverage Ratio | 16.285 | ▲1.274 | ▼-3.789 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-6.223 | ▼-37.002 |
| Operating Cash Flow Coverage Ratio | 0.525 | ▲0.043 | ▲0.101 |
| Capital Expenditure Coverage Ratio | 7.443 | ▲0.122 | ▲1.521 |
| Dividend Paid And Capex Coverage Ratio | 1.759 | ▲0.011 | ▲0.242 |
| Dividend Payout Ratio | 0.855 | ▲0.236 | ▲0.064 |
| Enterprise Value Multiple | 17.847 | ▲1.001 | ▼-1.200 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $63.90B | $74.34B | $65.95B | $65.90B | $72.11B | |
| Enterprise value | $70.60B | $81.75B | $74.05B | $74.40B | $79.11B | |
| EV / Sales | 3.46x | 4.07x | 3.81x | 4.14x | 4.54x | |
| EV / Op. cash flow | 16.82x | 19.91x | 19.77x | 29.11x | 23.79x | |
| EV / Free cash flow | 19.43x | 23.05x | 24.36x | 40.00x | 28.68x | |
| EV / EBITDA | 17.85x | 16.85x | 17.44x | 22.06x | 21.04x | |
| Net debt / EBITDA | 1.69x | 1.53x | 1.91x | 2.52x | 1.86x | |
| Current ratio | 0.99x | 0.92x | 1.11x | 1.28x | 1.08x | |
| Income quality | 1.97x | 1.35x | 1.52x | 1.30x | 1.42x | |
| Graham number | $2 | $5 | $7 | $5 | $6 | |
| Graham net-net | -$15 | -$15 | -$15 | -$14 | -$14 | |
| Tax burden | 69.7% | 73.0% | 67.8% | 67.1% | 70.2% | |
| Interest burden | 92.0% | 93.1% | 92.2% | 94.1% | 96.3% | |
| Working capital | -$27.0M | -$442.0M | $538.0M | $1.11B | $346.0M | |
| Invested capital | $9.29B | $9.01B | $10.42B | $10.69B | $9.82B | |
| Return on assets | 13.1% | 18.0% | 14.0% | 11.3% | 14.4% | |
| Operating ROA | 26.9% | 27.0% | 25.7% | 23.3% | 25.1% | |
| Return on tangible assets | 18.3% | 26.2% | 20.7% | 17.1% | 23.3% | |
| Return on equity | 3948.1% | 1362.7% | 377.7% | 445.1% | 355.7% | |
| Return on invested capital | 30.3% | 30.6% | 24.8% | 22.4% | 26.3% | |
| Return on capital employed | 41.0% | 42.6% | 35.5% | 30.6% | 35.4% | |
| Earnings yield | 3.3% | 3.9% | 3.5% | 2.7% | 3.0% | |
| Free cash flow yield | 5.7% | 4.8% | 4.6% | 2.8% | 3.8% | |
| Capex / Op. cash flow | 13.4% | 13.7% | 18.8% | 27.2% | 17.1% | |
| Capex / Depreciation | 89.5% | 92.7% | 124.3% | 127.7% | 102.0% | |
| Capex / Sales | 2.8% | 2.8% | 3.6% | 3.9% | 3.3% | |
| SG&A / Sales | 38.8% | 38.9% | 34.8% | 34.8% | 35.0% | |
| R&D / Sales | 0.0% | 1.8% | 1.8% | 1.8% | 1.8% | |
| Stock comp / Sales | 0.0% | 0.7% | 0.6% | 0.7% | 0.8% | |
| Intangibles / Total assets | 28.5% | 31.3% | 32.3% | 33.5% | 38.2% | |
| Days sales outstanding | 30d | 28d | 30d | 31d | 27d | |
| Days payables outstanding | 0d | 82d | 76d | 72d | 76d | |
| Operating cycle | 121d | 118d | 116d | 127d | 114d | |
| Cash conversion cycle | 121d | 36d | 40d | 55d | 38d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-06-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-10-07 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-10-06 | Rick Larsen | Sale | $1,001 - $15,000 |
| 2025-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-25 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-09-23 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-09-23 | Julie Johnson | Purchase | $1,001 - $15,000 |
| 2025-09-11 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-09-10 | Tim Moore | Sale | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-13 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-07-24 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-11 | Ritchie Torres | Sale (Full) | $1,001 - $15,000 |
| 2025-07-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-06-24 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-09 | Rick Larsen | Purchase | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-06 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-08-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-08-25 | Jeff Duncan | Sale (Full) | $1,001 - $15,000 |
| 2023-08-25 | Jeff Duncan | Sale Full | $1,001 - $15,000 |
| 2023-08-25 | Jeff Duncan | Sale Full | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-04-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-24 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-02-10 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-07 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-09-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-10 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-07-21 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-06-16 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Sale | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Sale | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Sale | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-04-07 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2021-02-10 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2021-01-28 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2020-12-30 | Sale (Full) | $1,001 - $15,000 | |
| 2020-04-29 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2020-03-23 | Zoe Lofgren | Sale (Full) | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill | Sale (Full) | $1,001 - $15,000 |
| 2020-01-15 | Mikie Sherrill | Purchase | $1,001 - $15,000 |
| 2019-12-12 | Mikie Sherrill | Sale (Full) | $1,001 - $15,000 |
| 2019-12-06 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2019-10-15 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2019-08-07 | Kevin Hern | Purchase | $15,001 - $50,000 |
| 2019-05-23 | Donna Shalala | Sale (Full) | $1,001 - $15,000 |
| 2019-04-30 | Tom Malinowski | Sale (Partial) | $1,001 - $15,000 |
| 2019-02-05 | Donna Shalala | Sale (Partial) | $1,001 - $15,000 |
| 2019-01-29 | Tom Malinowski | Sale (Partial) | $1,001 - $15,000 |
Recent news
- 2026-08-09 What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353 Cahill executed a sale of 4,170 shares on Aug. 6, 2026, realizing ~$389,353 in transaction value. The disposition reduced his total equity holdings by 6%, including shares acquired via option exercise, and 13% of his direct ownership.
- 2026-08-05 Colgate-Palmolive: The Reasons I Am Still Not A Buyer After The Q2 Results Colgate-Palmolive Company remains rated Hold due to valuation concerns, tepid organic growth, and persistent North American weakness. Q2 net sales rose 4.9%, but organic growth lagged at 2.4%, below both inflation and CL''s long-term target. Dividend and buyback returns are sustainable, but market pricing implies aggressive long-term growth assumptions not fully supported by fundamentals.
- 2026-07-31 Should Passive Income Investors Buy Colgate Palmolive Stock? Dividend stock investors have an excellent choice with this company.
- 2026-07-31 Colgate-Palmolive Co (CL) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Margin Expansion Amid US Challenges Organic Sales Growth: Organic sales growth was reported in four of five divisions and three of four categories.Emerging Markets Sales: Sales in emerging markets
- 2026-07-31 Colgate Q2 Earnings Beat Estimates on Strong Margins, Sales Rise 4.9% CL''s Q2 earnings beat as organic sales, productivity and margin gains offset higher brand investment, while Latin America led regional growth.
- 2026-07-31 Colgate-Palmolive Q2 Earnings Call Highlights Colgate-Palmolive NYSE: CL said its second-quarter 2026 results reflected broad-based organic sales growth, gross-margin expansion and higher advertising spending, while executives outlined steps to improve performance in North America amid softer category trends and elevated competition.
- 2026-07-31 Colgate-Palmolive Company (CL) Q2 2026 Earnings Call Transcript Colgate-Palmolive Company (CL) Q2 2026 Earnings Call Transcript
- 2026-07-31 Pre-Market Trading Up in Final Session of the Week Despite some mid-week turbulence, we''re trading fairly even with where we were as of mid-day Monday.
- 2026-07-31 Colgate-Palmolive: Steady Globally, Weak Domestically Colgate-Palmolive Company reported stable overall Q2 results. Organic revenues grew moderately, and margins stayed good. Growth varies by market. CL''s advertising investments are yielding results in Latin America and Asia Pacific, but competitive pressure is weakening results in North America. I estimate CL stock to have a fair value of $92.4.
- 2026-07-31 Colgate-Palmolive (CL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.